(All fields required)
Please enter a valid email.
Please enter your name.
The goal of the Kahn research lab is to conduct interdisciplinary clinical and epidemiologic studies related to prevention of cervical cancer and other diseases caused by human papillomavirus (HPV), in the United States and globally.
We have conducted studies that:
Charlton BM, Corliss HL, Missmer SA, Frazier AL, Rosaria M, Kahn JA, Austin SB. Reproductive health screening disparities and sexual orientation in a cohort study of U.S. adolescent and young adult females. Journal of Adolescent Health. In press.
Mullins TL, Zimet GD, Rosenthal SL, Morrow C, Ding L, Shew M, Fortenberry JD, Bernstein DI, Kahn JA. Adolescent perceptions of risk and need for safer sexual behaviors after first HPV vaccination. Archives of Pediatrics and Adolescent Medicine. In press.
Kahn JA, Huang B, Ding L, Geller A, Frazier, AL. Impact of Maternal Communication About Skin, Cervical, and Lung Cancer Prevention on Adolescent Prevention Behaviors. Journal of Adolescent Health. 2011.
Friedman L, Bell DL, Kahn JA, Marcell AV, Middleman AB, Rosenthal SL, Zimet GD. Human papillomavirus vaccine: an updated position statement of the Society for Adolescent Health and Medicine. Journal of Adolescent Health. 48:215-6. 2011.
Feldman S, Kahn JA, Hillard PJ. HPV Infection in Children and Adolescents. In: Emans SJ, Laufer MR, Goldstein DP, Eds. Pediatric and Adolescent Gynecology, 6th Ed., Philadelphia: Lippincott-Raven, in press.
Feemster K, Kahn JA, Hillard PJ. HPV Vaccine 2011. Contemporary Obstetrics and Gynecology. In press, 2011.
Mullins TK, Braverman PK, Dorn LD, Kollar LM, Kahn JA. Adolescents' Agreement to Test for HIV When Different Testing Methods are Offered. International Journal of STD & AIDS. In press.
Huppert JS, Hesse EA, Bernard MA, Xiao Y, Huang B, Gaydos CA, Kahn JA.Acceptability of self-testing for Trichomoniasis increases with experience. Sexually Transmitted Infections; in press.
Mullins TK, Braverman PK, Dorn LD, Kollar LM, Kahn JA. Adolescent Preferences for Human Immunodeficiency Virus Testing Methods and Impact of Rapid Tests on Receipt of Results. Journal of Adolescent Health. 46:162-8. 2010.
Mullins TK, Kollar LM, Lehmann C, Kahn JA. Changes in human immunodeficiency virus testing rates among urban adolescents after introduction of routine and rapid testing. Archives of Pediatrics and Adolescent Medicine. 164:870-74. 2010.
Widdice LE, Bernstein DI, Leonard AC, Marsolo KA, Kahn JA. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics. 127:77-84. 2010.
Feemster K, Kahn JA. HPV Vaccine: Meeting the Challenge. Contemporary Pediatrics. 27:34-43. 2010.
Fernandez ME, Allen JD, Mistry R, Kahn JA. Integrating clinical, community, and policy perspectives on human papillomavirus vaccination. Annual Review of Public Health. 31:235-52. 2010.
Kharbanda EO, Kahn JA. Vaccinating teens: current guidelines, challenges, and opportunities. Pediatric Annals. 2010.
Kahn JA, Ding L, Huang B, Zimet GD, Rosenthal SL, Frazier AL. Mothers’ intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics. 123:1439-1445. 2009.
Pattullo L, Griffeth S, Ding, L, Mortensen J, Reed J, Kahn J, Huppert J. Stepwise diagnosis of Trichomonas vaginalis infection in adolescent women. Journal of Clinical Microbiology. 47:59-63. 2009.
Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S, Kahn JA. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. Journal of Women’s Health. 18:1679-86. 2009.
Kahn JA, Cooper HP, Vadaprampil S, Pence B, Weinberg A, Rosenthal SL. Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12- year-old girls: a statewide survey of Texas physicians. Cancer Epidemiology Biomarkers and Prevention. 18:2325-32. 2009.
HPV Vaccine Expert Advisory Committee. Background document on HPV vaccines for Strategic Advisory Group of Experts (SAGE) on Immunization. World Health Organization, Weekly Epidemiological Record, Jan. 9, 2009, vol. 84, 1/2 (pp. 1-16).
Human Papillomavirus Vaccines Position Paper. World Health Organization, Weekly Epidemiological Record, April 10, 2009, vol. 84, 15 (pp 117–132).
Shikary T, Bernstein DI, Jin Y, Zimet GD, Rosenthal SL, Kahn JA. Epidemiology and risk factors for human papillomavirus infection in a diverse sample of low-income young women. Journal of Clinical Virology. 46:107-111. 2009.
Morreale RJ, Kahn JA, Butsch Kovacic M, Hegde RS, Aronow BJ, Wells SI. Insights from the transcriptional profiling of human papillomavirus infection and associated carcinogenesis. In: Yoshida K (Ed.). Molecular Biology of Tumor Virus Gene Products. Kerala, India: Research Signpost, 169-96. 2009.
Kahn JA, Higgins L, Usher-Patel M, Broutet N. The HPV Vaccine Global Community of Practice: A Model for Global Discussion about Cervical Cancer and the Role of HPV Vaccines. HPV Today 19:12-13. 2009.
Kahn JA. HPV vaccination for the prevention of cervical intraepithelial neoplasia. New England Journal of Medicine. 361:271-8. 2009.
Gray SH, Austin SB, Huang B, Frazier AL, Field A, Colditz GA, Kahn JA. Predicting sexual initiation in a prospective cohort study of adolescents. Archives of Pediatrics and Adolescent Medicine. 162:55-59. 2008.
Kahn JA. Human Papillomavirus Infection and Anogenital Warts (Chapter 66). In: Neinstein LS, Gordon G, Katzman D, Woods ER, Rosen D, Eds. Adolescent Health Care: A Practical Guide, 5th Edition; 842-849. 2008.
Kahn, JA. Sexual disinhibition and HPV vaccination. Journal of Adolescent Health. 42:106-107. 2008.
Zimet GD, Kahn JA, Shew M. Appropriate use of cervical cancer vaccines. Annual Review of Medicine. 59:223-36. 2008.
Schneider G, Kahn JA. Human papillomavirus and cervical cytology (Chapter 27). In: Slap GB, Ed. Adolescent Medicine: The Requisites in Pediatrics. Philadelphia: Elsevier; 202-210. 2008.
Kahn JA. Polycystic ovary syndrome in adolescents (Chapter 23). In: Slap GB, Ed. Adolescent Medicine: The Requisites in Pediatrics. Philadelphia: Elsevier, 165-174. 2008.
Widdice LE, Kahn JA. Sexually Transmitted Disease: Human Papillomavirus. In: The 5-Minute Ob/Gyn Clinical Consult. Philadelphia: Lippincott Williams & Wilkins 174-175. 2008.
Kollar LM, Kahn JA. Educating about human papillomavirus and human papillomavirus vaccines in adolescents. Current Opinion in Obstetrics and Gynecology. 20:479-83. 2008.
Kahn JA, Huang B, Gillman MW, Field AE, Austin SB, Colditz G, Frazier AL. Patterns and determinants of physical activity in U.S. adolescents. Journal of Adolescent Health. 42:369-77. 2008.
Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, Zimet GD. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstetrics and Gynecology. 111:1103-1110. 2008.
Feemster KA, Winters SE, Fiks AG, Kinsman S, Kahn JA. Pediatricians’ intention to recommend human papillomavirus (HPV) vaccines to 11- to 12-year-old girls postlicensing. Journal of Adolescent Health. 43:408-11. 2008.
Jessica A. Kahn, MD, MPHDivision of Adolescent Medicine 3333 Burnet Ave. MLC 4000Cincinnati, OH 45229
Phone: 513-636-2970Fax: 513-636-1129Email: email@example.com
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the tri-state area? 1-877-881-8479
© 1999-2013 Cincinnati Children's Hospital Medical Center